PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.06%
Positive revenue growth while 3088.T is negative. John Neff might see a notable competitive edge here.
3.06%
Positive gross profit growth while 3088.T is negative. John Neff would see a clear operational edge over the competitor.
-44.76%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-7.53%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-34.48%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-34.48%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-34.48%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
45.54%
10Y revenue/share CAGR above 1.5x 3088.T's 27.92%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
54.62%
5Y revenue/share CAGR above 1.5x 3088.T's 2.11%. David Dodd would look for consistent product or market expansions fueling outperformance.
25.47%
Positive 3Y CAGR while 3088.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
62.16%
Net income/share CAGR 1.25-1.5x 3088.T's 44.74%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
72.44%
5Y net income/share CAGR 1.25-1.5x 3088.T's 51.05%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
-3.19%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
187.26%
10Y equity/share CAGR 1.25-1.5x 3088.T's 127.29%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
123.92%
5Y equity/share CAGR above 1.5x 3088.T's 43.59%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
56.65%
3Y equity/share CAGR above 1.5x 3088.T's 20.30%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-21.43%
Cut dividends over 10 years while 3088.T stands at 34661.42%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
57.14%
Similar 5Y dividend/share CAGR to 3088.T's 55.56%. Walter Schloss sees parallel philosophies in mid-term capital returns.
22.22%
3Y dividend/share CAGR 1.25-1.5x 3088.T's 16.67%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
16.28%
Our AR growth while 3088.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
8.26%
We show growth while 3088.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.92%
Asset growth above 1.5x 3088.T's 0.92%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.38%
BV/share growth above 1.5x 3088.T's 1.66%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
75.68%
Debt growth far above 3088.T's 28.80%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
6.04%
We expand SG&A while 3088.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.